Vir Biotechnology Future Growth
Future criteria checks 2/6
Vir Biotechnology's earnings are forecast to decline at 1.7% per annum while its annual revenue is expected to grow at 23.8% per year. EPS is expected to grow by 6.5% per annum. Return on equity is forecast to be -45.1% in 3 years.
Key information
-1.7%
Earnings growth rate
6.5%
EPS growth rate
Biotechs earnings growth | 25.0% |
Revenue growth rate | 23.8% |
Future return on equity | -45.1% |
Analyst coverage | Good |
Last updated | 07 May 2024 |
Recent future growth updates
Recent updates
Earnings Update: Vir Biotechnology, Inc. (NASDAQ:VIR) Just Reported And Analysts Are Boosting Their Estimates
May 05Vir Biotechnology Provides Some Hope For Its Beleaguered Shareholders
May 03Vir Biotechnology: Making Progress In Hepatitis B And Hepatitis Delta
Feb 28Sticking With Vir Biotechnology
Jan 17Vir Biotechnology, Inc. (NASDAQ:VIR) Analysts Just Slashed This Year's Revenue Estimates By 37%
Aug 07Revenues Working Against Vir Biotechnology, Inc.'s (NASDAQ:VIR) Share Price Following 42% Dive
Jul 24Analysts Just Shaved Their Vir Biotechnology, Inc. (NASDAQ:VIR) Forecasts Dramatically
Feb 28Vir Biotechnology, Inc. (NASDAQ:VIR) Shares Could Be 26% Below Their Intrinsic Value Estimate
Jan 07Vir Biotechnology: Focus On Hepatitis B Development Could End Up Paying Off
Oct 12Vir Biotech gains 12% as U.S. govt. inks multi-year deal worth up to $1B
Oct 04Vir begins dosing in mid-stage study of VIR-2218, VIR-3434 for hepatitis D virus
Sep 22Vir Biotechnology falls 15% on Q2 revenue miss impacted by ~$400M for potential write-offs
Aug 09Vir: Biotechnology's Best Near-Term Capital Gain Prospect
Jul 27Vir Biotechnology announces transition of chief scientific officer
Jul 14Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 56 | -606 | -534 | -436 | 7 |
12/31/2025 | 39 | -579 | -505 | -395 | 8 |
12/31/2024 | 80 | -485 | -418 | -326 | 8 |
3/31/2024 | 80 | -539 | -779 | -762 | N/A |
12/31/2023 | 86 | -615 | -800 | -779 | N/A |
9/30/2023 | 119 | -601 | -668 | -636 | N/A |
6/30/2023 | 491 | -262 | -410 | -362 | N/A |
3/31/2023 | 446 | -144 | 928 | 987 | N/A |
12/31/2022 | 1,616 | 516 | 1,595 | 1,663 | N/A |
9/30/2022 | 2,379 | 1,143 | 1,567 | 1,636 | N/A |
6/30/2022 | 2,108 | 1,078 | 1,357 | 1,412 | N/A |
3/31/2022 | 2,326 | 1,216 | 555 | 592 | N/A |
12/31/2021 | 1,095 | 529 | -69 | -48 | N/A |
9/30/2021 | 284 | -102 | -149 | -137 | N/A |
6/30/2021 | 183 | -297 | -88 | -81 | N/A |
3/31/2021 | 73 | -390 | -238 | -232 | N/A |
12/31/2020 | 76 | -299 | -197 | -191 | N/A |
9/30/2020 | 76 | -257 | -153 | -148 | N/A |
6/30/2020 | 75 | -220 | -140 | -135 | N/A |
3/31/2020 | 10 | -223 | -155 | -149 | N/A |
12/31/2019 | 8 | -175 | -139 | -130 | N/A |
9/30/2019 | 10 | -137 | -130 | -120 | N/A |
6/30/2019 | 12 | -122 | -128 | -118 | N/A |
3/31/2019 | 12 | -117 | -119 | -109 | N/A |
12/31/2018 | 11 | -116 | -104 | -94 | N/A |
12/31/2017 | 3 | -70 | N/A | -66 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: VIR is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: VIR is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: VIR is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: VIR's revenue (23.8% per year) is forecast to grow faster than the US market (8.3% per year).
High Growth Revenue: VIR's revenue (23.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: VIR is forecast to be unprofitable in 3 years.